Swiss pharmaceutical giant Novartis on Friday reported better-than-expected sales in the fourth quarter.
Fourth-quarter net sales rose 16% on a constant currency basis to $13.2 billion, compared to the $12.795 billion estimated by analysts in an LSEG poll.
